Drug Approval | May 20, 2023
Granules India received ANDA approval for Venlafaxine ER capsules
Venlafaxine HCl extended-release capsules are indicated for the treatment of: Major Depressive Disorder
Venlafaxine HCl extended-release capsules are indicated for the treatment of: Major Depressive Disorder
Gabapentin Tablets are indicated for management of postherpetic neuralgia in adults
Marksans' OTC Famotidine Tablets USP are acid reducers
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
Losartan potassium tablets are indicated for the treatment of hypertension in adults and pediatric patients 6 years of age and older, to lower blood pressure.
Granules now have a total of 53 ANDA approvals from USFDA
Supriya Lifescience Limited has informed that the European Directorate for the Quality of Medicines (EDQM) has granted Attestation of Inspection (EU-GMP) for Lote API Facility, Ratnagiri, Maharashtra.
This product is based on Osmotic Controlled Release Oral Delivery System technology
The product is expected to be launched by Q4 FY23.
The approval further strengthens the Potassium Chloride franchise for the company.
Subscribe To Our Newsletter & Stay Updated
